Clinical Trials Browser

Phase 2 × Unknown × Angiogenesis Inhibitors × Clear all

NCT04459078 2022-12-02

Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma

Phase 2 Unknown

Adenocarcinoma of Lung

NCT03461185 2018-03-09

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung